-
admin
Posts
Maropost unveils AI-powered email marketing features that boost conversions for commerce brands
TORONTO, Dec. 6, 2024 /PRNewswire/ — Maropost, the connected commerce platform revolutionizing mid-market merchant operations, today announced two groundbreaking AI-driven features for its Marketing Cloud...
2024 “Nanjing Week” at UNESCO: Deepening Civilizational Exchanges and Mutual Learning through Revival of Silk Road Heritage
NANJING, China, Dec. 06, 2024 (GLOBE NEWSWIRE) — Following the “Brocade and embroidery, a fibre which connects us” themed art exhibition held at the Louvre...
Growth Trends in the Mobile Gaming Industry, 2024-2029
Mobile Gaming Market Soars with 5G Revolution, AAA-Quality Games, and Free-to-Play Models Redefining Global Entertainment Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) — The “Mobile Gaming...
Leading AI-driven Skin Analysis Provider EveLab Insight Partners with Dr. Idriss for Series of Retail Activations
SINGAPORE, Dec. 05, 2024 (GLOBE NEWSWIRE) — EveLab Insight, a leading provider of AI-driven skin analysis services, has partnered with Dr. Idriss, a science backed...
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative Paris, France and Geneva, Switzerland (6...
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative
OneSight EssilorLuxottica Foundation Joins Forces with World Health Organization to Advance Global Vision Care Under WHO SPECS 2030 Initiative Paris, France and Geneva, Switzerland (6...
Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Availability of the revised financial statements for Sanofi excluding Opella Paris, France – December 6, 2024. Following the press release on October 21, 2024 and...
New Phase IIIB data shows Novartis Fabhalta® improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy
In the Phase IIIB APPULSE-PNH study, oral Fabhalta® (iptacopan) improved the average hemoglobin (Hb) level versus baseline in adult patients with paroxysmal nocturnal hemoglobinuria (PNH)...
Press Release: Sequana Medical announces decision of major shareholders to invest in Second Tranche of Convertible Bridge Loan
SEQUANA MEDICAL ANNOUNCES DECISION OF MAJOR SHAREHOLDERS TO INVEST IN SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium, 6 December 2024 – Sequana Medical NV...
L’Oréal teams up with Visionairs for the opening of the world-touring “Notre-Dame de Paris: The Augmented Exhibition” in Hong Kong today
Traveling back in time to celebrate the Cathedral’s legacy and the power of cultural beauty through immersive technology HONG KONG, Dec. 6, 2024 /PRNewswire/ —...
